Updated: June 13, 2026
About the program
Program type
Description
Originates companies via a Fidelity-backed formation engine, combining healthcare and tech expertise to syndicate founders globally and favor technical feasibility over regulatory risk in rare diseases and gene therapy.
Location
Countries invested
Investment offer
Can lead rounds
Yes
Details
Avg Check: $100K - $10M ·